levothyroxine sodium
NDC 47781-649, levothyroxine sodium, tablet, from Alvogen, Inc..
- Product NDC
- 47781-649
- Status
- Listed
- Labeler
- Alvogen, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021116
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47781-649 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE SODIUM88 ug/1
Pharmacologic classes
Thyroxine [CS]; l-Thyroxine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-649-10 | 47781064910 | 1000 TABLET in 1 BOTTLE (47781-649-10) |
| 47781-649-90 | 47781064990 | 90 TABLET in 1 BOTTLE (47781-649-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4ddcaec1-a58f-340b-9bc1-bbe048b8c885NADAC price for package 47781064910
GET /v1/drugs/nadac/47781064910NADAC price for package 47781064990
GET /v1/drugs/nadac/47781064990
Use it
Look up 47781-649 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-649 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-649. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.